Yiji Liao
0000-0002-0849-4573
Publication & Citation Trends
Publications
0 total
Tumour-intrinsic PDL1 signals regulate the Chk2 DNA damage response in cancer cells and mediate resistance to Chk1 inhibitors OA
Cited by 8
Semantic Scholar
Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive through NK cell effects OA
Cited by 10
Semantic Scholar
Inhibition of EZH2 transactivation function sensitizes solid tumors to genotoxic stress OA
Cited by 47
Semantic Scholar
PRC2-mediated epigenetic suppression of type I IFN-STAT2 signaling impairs antitumor immunity in luminal breast cancer. OA
Cited by 18
Semantic Scholar
Tumor-intrinsic PD-L1 promotes DNA repair in distinct cancers and suppresses PARP inhibitor-induced synthetic lethality. OA
Cited by 41
Semantic Scholar
Regulation of telomere homeostasis and genomic stability in cancer by N6-adenosine methylation (m6A) OA
Cited by 35
Semantic Scholar
Enhancer RNAs Mediate Estrogen-Induced Decommissioning of Selective Enhancers by Recruiting ERα and Its Cofactor OA
Cited by 23
Semantic Scholar
4-Methoxy Sulfonyl Paeonol Inhibits Hepatic Stellate Cell Activation and Liver Fibrosis by Blocking the TGF-β1/Smad, PDGF-BB/MAPK and Akt Signaling Pathways OA
Cited by 3
Semantic Scholar
Research Topics
Cancer-related molecular mechanisms research
(19)
T-cell and Retrovirus Studies
(17)
Epigenetics and DNA Methylation
(15)
Circular RNAs in diseases
(15)
MicroRNA in disease regulation
(12)
Affiliations
Dartmouth College
Nanchang University
Sun Yat-sen University
The University of Texas Health Science Center at San Antonio
Longgang Central Hospital